Tesamorelin reduces visceral fat in HIV lipodystrophy
New England Journal of Medicine
2010
Study summary
Tesamorelin evaluated for visceral adipose reduction.
Peptides studied
Stack studied
GH Optimization Stack
Key findings
Significant decreases in visceral adipose tissue observed.
Study details
Study type
randomized clinical trial
Journal
New England Journal of Medicine
DOI / PubMed
10.1056/NEJMoa0911289
Year
2010
Explore peptide profiles
Discover compounds, understand their mechanisms, and explore the research behind each peptide.
